Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc.

NASDAQ:TYRA

Overview | Financials
Company Name Tyra Biosciences, Inc.
Symbol TYRA
Currency USD
Price 10.92
Market Cap 580,703,651
Dividend Yield 0%
52-week-range 6.42 - 29.6
Industry Biotechnology
Sector Healthcare
CEO Dr. Todd Harris Ph.D.
Website https://www.tyra.bio

An error occurred while fetching data.

About Tyra Biosciences, Inc.

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing

Related Stocks

Esperion Therapeutics, Inc. logo

Esperion Therapeutics, Inc.

ESPR

1.12 USD

Monte Rosa Therapeutics, Inc. logo

Monte Rosa Therapeutics, Inc.

GLUE

5.61 USD

Belite Bio, Inc logo

Belite Bio, Inc

BLTE

62.05 USD

Regencell Bioscience Holdings Limited logo

Regencell Bioscience Holdings Limited

RGC

15.29 USD

Arcellx, Inc. logo

Arcellx, Inc.

ACLX

70.7 USD

Inotiv, Inc. logo

Inotiv, Inc.

NOTV

1.855 USD

Kodiak Sciences Inc. logo

Kodiak Sciences Inc.

KOD

4.735 USD

MeiraGTx Holdings plc logo

MeiraGTx Holdings plc

MGTX

8.67 USD

Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc.

VRDN

16.79 USD

Financials

Numbers are in millions USD

Numbers are in millions USD